| Name | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
| Description | This gene encodes a nuclear-encoded mitochondrial bifunctional enzyme with methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase activities. The enzyme functions as a homodimer and is unique in its absolute requirement for magnesium and inorganic phosphate. Formation of the enzyme-magnesium complex allows binding of NAD. Alternative splicing results in two different transcripts, one protein-coding and the other not protein-coding. This gene has a pseudogene on chromosome 7. [provided by RefSeq, Mar 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMTHFD2 is a mitochondrial enzyme that plays a central role in one‐carbon metabolism by providing essential one‐carbon units for nucleotide synthesis, methylation reactions, and redox homeostasis. This enzyme is normally expressed during embryonic development, but its re‐expression in many adult malignancies supports rapid tumor cell proliferation and survival. Elevated levels of MTHFD2 have been observed across a wide range of cancers—including breast, colorectal, acute myeloid leukemia and renal, among others—often correlating with poor prognosis and aggressive disease. In several studies, its overexpression has been linked to metabolic remodeling in cancer cells, such as the induction of a glycine auxotrophy in breast cancer and a shift toward purine biosynthesis in leukemic and endothelial models, highlighting its function as a key metabolic node."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical metabolic role, MTHFD2 exhibits non‐metabolic and regulatory functions that contribute to tumor progression. It has been implicated in maintaining genomic stability by modulating DNA repair processes such as nonhomologous end joining and by influencing replication fork dynamics, which can result in replication stress when perturbed. Moreover, MTHFD2 engages in “moonlighting” activities—such as interacting with key cell cycle regulators (for example, direct association with CDK2 in bladder cancer) and enhancing oncogenic signaling through pathways such as AKT/GSK‐3β/β‐catenin or STAT3 activation. Its expression is also regulated at multiple levels, including alternative splicing and post‐translational modifications, and is modulated by oncogenic drivers (like MYCN) and microRNAs."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, MTHFD2 functions as an adaptive regulator and prognostic biomarker by modulating tumor cell “stemness,” drug resistance, and immune evasion. It influences the cellular response to nutrient stress—such as during glutamine deprivation or oxidative challenges—by linking metabolic flux to stress response pathways like the unfolded protein response. In some tumor types, disruption of MTHFD2 not only impairs metabolic homeostasis but also alters cell–cell signaling (for example, by promoting PD‐L1 expression via the PI3K/AKT pathway), thereby affecting the tumor microenvironment and response to therapy. Its dysregulated expression, sometimes mediated by upstream noncoding RNAs or genetic polymorphisms, has been associated with adverse clinical parameters in cancers ranging from glioblastoma and ovarian to endometrial, esophageal, and gastric carcinomas."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Gary M Shaw, Wei Lu, Huiping Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2350-10-49"}], "href": "https://doi.org/10.1186/1471-2350-10-49"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19493349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19493349"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Laura Lehtinen, Kirsi Ketola, Rami Mäkelä, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.756"}], "href": "https://doi.org/10.18632/oncotarget.756"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23295955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23295955"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Roland Nilsson, Mohit Jain, Nikhil Madhusudhan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms4128"}], "href": "https://doi.org/10.1038/ncomms4128"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24451681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24451681"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Feng Liu, Yang Liu, Chuan He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased MTHFD2 expression is associated with poor prognosis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-2111-x"}], "href": "https://doi.org/10.1007/s13277-014-2111-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24870594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24870594"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Nina Gustafsson Sheppard, Lisa Jarl, Diana Mahadessian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep15029"}], "href": "https://doi.org/10.1038/srep15029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26461067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26461067"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xincheng Liu, Yu Huang, Chenglong Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dig Liver Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.dld.2016.04.015"}], "href": "https://doi.org/10.1016/j.dld.2016.04.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27257051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27257051"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Costas Koufaris, Suchira Gallage, Tianlai Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.jproteome.6b00188"}], "href": "https://doi.org/10.1021/acs.jproteome.6b00188"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27315223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27315223"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yana Pikman, Alexandre Puissant, Gabriela Alexe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting MTHFD2 in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20151574"}], "href": "https://doi.org/10.1084/jem.20151574"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27325891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27325891"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Robert Gustafsson, Ann-Sofie Jemth, Nina M S Gustafsson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-16-1476"}], "href": "https://doi.org/10.1158/0008-5472.CAN-16-1476"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27899380"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27899380"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yueli Gu, Jinchun Si, Xichun Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504016X14829256525028"}], "href": "https://doi.org/10.3727/096504016X14829256525028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28059050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28059050"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Juliane Hitzel, Eunjee Lee, Yi Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-04602-0"}], "href": "https://doi.org/10.1038/s41467-018-04602-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29895827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29895827"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hao Lin, Bin Huang, Hua Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000495402"}], "href": "https://doi.org/10.1159/000495402"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30466107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30466107"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tatsunori Nishimura, Asuka Nakata, Xiaoxi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0589-1"}], "href": "https://doi.org/10.1038/s41388-018-0589-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30532069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30532069"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yan Yan, Ding Zhang, Ting Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Pharmacol Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1440-1681.13125"}], "href": "https://doi.org/10.1111/1440-1681.13125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31209892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31209892"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Nathanael H Green, Daniel L Galvan, Shawn S Badal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-019-0869-4"}], "href": "https://doi.org/10.1038/s41388-019-0869-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31289360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31289360"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "R Nilsson, V Nicolaidou, C Koufaris "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2019.144032"}], "href": "https://doi.org/10.1016/j.gene.2019.144032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31377316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31377316"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Chantal Hoi Yin Cheung, Chia-Lang Hsu, Chao-Yin Tsuei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-2033-z"}], "href": "https://doi.org/10.1038/s41419-019-2033-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31624245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31624245"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Chang Yu, Lehe Yang, Mengsi Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14844"}], "href": "https://doi.org/10.1111/jcmm.14844"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31778025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31778025"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Huan He, Peng-Cheng Li, Wei Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.920259"}], "href": "https://doi.org/10.12659/MSM.920259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32088725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32088725"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Vicky Nicolaidou, Christos Papaneophytou, Costas Koufaris "}, {"type": "b", "children": [{"type": "t", "text": "Detection and characterisation of novel alternative splicing variants of the mitochondrial folate enzyme MTHFD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-020-05775-y"}], "href": "https://doi.org/10.1007/s11033-020-05775-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32880830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32880830"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jianlin Wang, Judong Luo, Zhiqiang Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000022194"}], "href": "https://doi.org/10.1097/MD.0000000000022194"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32925794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32925794"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Q-Q Geng, Q-F Wu, Y Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202009_23032"}], "href": "https://doi.org/10.26355/eurrev_202009_23032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33015789"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33015789"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Kazuhiro Tanaka, Takashi Sasayama, Hiroaki Nagashima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glioma cells require one-carbon metabolism to survive glutamine starvation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-020-01114-1"}], "href": "https://doi.org/10.1186/s40478-020-01114-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33468252"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33468252"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Man Shang, Huijie Yang, Ran Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-22173-5"}], "href": "https://doi.org/10.1038/s41467-021-22173-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33782411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33782411"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yangfeng Shi, Yiming Xu, Jianchang Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.16715"}], "href": "https://doi.org/10.1111/jcmm.16715"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34121323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34121323"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Qiutong Li, Fang Yang, Xiu Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Open Bio (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/2211-5463.13249"}], "href": "https://doi.org/10.1002/2211-5463.13249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34231329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34231329"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Gen Li, Jun Wu, Le Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2019822118"}], "href": "https://doi.org/10.1073/pnas.2019822118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34244426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34244426"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xi Liu, Shuangjie Liu, Chiyuan Piao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.15159"}], "href": "https://doi.org/10.1111/cas.15159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34632667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34632667"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Xiangrong Cui, Huancheng Su, Jiaolin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Ovarian Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13048-022-00954-w"}], "href": "https://doi.org/10.1186/s13048-022-00954-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35135596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35135596"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Nadilly Bonagas, Nina M S Gustafsson, Martin Henriksson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s43018-022-00331-y"}], "href": "https://doi.org/10.1038/s43018-022-00331-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35228749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35228749"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Fan Zhang, Di Wang, Jintao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Biol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jmcb/mjac020"}], "href": "https://doi.org/10.1093/jmcb/mjac020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35349697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35349697"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Qian Chen, Peng Huang, Xin-Li Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Association of maternal "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MTHFD1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MTHFD2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " gene polymorphisms with congenital heart disease in offspring]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Dang Dai Er Ke Za Zhi (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7499/j.issn.1008-8830.2203002"}], "href": "https://doi.org/10.7499/j.issn.1008-8830.2203002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35894196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35894196"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Yixing Gao, Lan Feng, Luping Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/7527996"}], "href": "https://doi.org/10.1155/2022/7527996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36051358"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36051358"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Zhiyuan Zhu, Karrie Mei-Yee Kiang, Ning Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2022.215903"}], "href": "https://doi.org/10.1016/j.canlet.2022.215903"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36089117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36089117"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Abhinav Achreja, Tao Yu, Anjali Mittal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Metab (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42255-022-00636-3"}], "href": "https://doi.org/10.1038/s42255-022-00636-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36131208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36131208"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Meihui Huang, Jiajian Xue, Zhiming Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2 suppresses glioblastoma progression via the inhibition of ERK1/2 phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Cell Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1139/bcb-2022-0291"}], "href": "https://doi.org/10.1139/bcb-2022-0291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36493392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36493392"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Xinxi Deng, Xiaoqiang Liu, Bing Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of MTHFD2 is associated with PD‑L1 activation in bladder cancer via the PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2022.5217"}], "href": "https://doi.org/10.3892/ijmm.2022.5217"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36601741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36601741"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Sa Wu, Weisong Cai, Yanli Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SNHG3/hsa-miR-455-5p Axis-mediated High Expression of MTHFD2 Correlates with Tumor Immune Infiltration and Endometrial Carcinoma Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.81962"}], "href": "https://doi.org/10.7150/ijms.81962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37484807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37484807"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Jie Wang, Ze Yu, Yixiao Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Biosci (Landmark Ed) (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.31083/j.fbl2901035"}], "href": "https://doi.org/10.31083/j.fbl2901035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38287824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38287824"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Rafaela V N Silva, Lucas A Berzotti, Marcella G Laia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Implications of MTHFD2 expression in renal cell carcinoma aggressiveness."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0299353"}], "href": "https://doi.org/10.1371/journal.pone.0299353"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38422037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38422037"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Hai-Yu Mo, Ruo-Bing Wang, Meng-Yao Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Rep (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/13510002.2024.2345455"}], "href": "https://doi.org/10.1080/13510002.2024.2345455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38723197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38723197"}]}]}]}
|
| Synonyms | NMDMC |
| Proteins | MTDC_HUMAN |
| NCBI Gene ID | 10797 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MTHFD2 has 13,111 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 131 datasets.
Click the + buttons to view associations for MTHFD2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by MTHFD2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MTHFD2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MTHFD2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MTHFD2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MTHFD2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MTHFD2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MTHFD2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MTHFD2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MTHFD2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MTHFD2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MTHFD2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MTHFD2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MTHFD2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing MTHFD2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MTHFD2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MTHFD2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MTHFD2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MTHFD2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MTHFD2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MTHFD2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MTHFD2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MTHFD2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MTHFD2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MTHFD2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MTHFD2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MTHFD2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MTHFD2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MTHFD2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MTHFD2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MTHFD2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for MTHFD2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MTHFD2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MTHFD2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MTHFD2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MTHFD2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MTHFD2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MTHFD2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MTHFD2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MTHFD2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MTHFD2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MTHFD2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MTHFD2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MTHFD2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MTHFD2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MTHFD2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MTHFD2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MTHFD2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MTHFD2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MTHFD2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MTHFD2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MTHFD2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MTHFD2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with MTHFD2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with MTHFD2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for MTHFD2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MTHFD2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MTHFD2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MTHFD2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MTHFD2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving MTHFD2 protein from the HumanCyc Pathways dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MTHFD2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MTHFD2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MTHFD2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MTHFD2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MTHFD2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving MTHFD2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving MTHFD2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MTHFD2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MTHFD2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MTHFD2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MTHFD2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MTHFD2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MTHFD2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MTHFD2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MTHFD2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MTHFD2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MTHFD2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MTHFD2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MTHFD2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MTHFD2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for MTHFD2 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MTHFD2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for MTHFD2 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MTHFD2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing MTHFD2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PANTHER Pathways | pathways involving MTHFD2 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MTHFD2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MTHFD2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MTHFD2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MTHFD2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MTHFD2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving MTHFD2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MTHFD2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MTHFD2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MTHFD2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MTHFD2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MTHFD2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MTHFD2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MTHFD2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MTHFD2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MTHFD2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MTHFD2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of MTHFD2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MTHFD2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MTHFD2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MTHFD2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MTHFD2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MTHFD2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MTHFD2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MTHFD2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MTHFD2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MTHFD2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MTHFD2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving MTHFD2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MTHFD2 protein from the WikiPathways Pathways 2024 dataset. | |